N-(pyrimidin-4-yl) and N-(pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists

被引：10

作者：

Porter, JR ^{[1
]}

Archibald, SC ^{[1
]}

Brown, JA ^{[1
]}

Childs, K ^{[1
]}

Critchley, D ^{[1
]}

Head, JC ^{[1
]}

Hutchinson, B ^{[1
]}

Parton, TAH ^{[1
]}

Robinson, MK ^{[1
]}

Shock, A ^{[1
]}

Warrellow, GJ ^{[1
]}

Zomaya, A ^{[1
]}

机构：

[1] Celltech R&D Ltd, Slough SL1 4EN, Berks, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 12期

关键词：

D O I：

10.1016/S0960-894X(02)00241-X

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The SAR studies to optimise both potency and rate of clearance in the rat for a series of pyrimidine and pyridine based VLA-4 antagonists are described. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：1595 / 1598

页数：4

共 13 条

[1] Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists [J].

Archibald, SC ;

Head, JC ;

Gozzard, N ;

Howat, DW ;

Parton, TAH ;

Porter, JR ;

Robinson, MK ;

Shock, A ;

Warrellow, GJ ;

Abraham, WM .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (09) :997-999

[2] Diamine containing VLA-4 antagonists [J].

Astles, PC ;

Harris, NV ;

Morley, AD .

BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (08) :2195-2202

[3] N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists.: 3.: Structure-activity relationship and optimization of the N-aryl substituent [J].

Cobb, JE ;

Blanchard, SG ;

Boswell, EG ;

Brown, KK ;

Charifson, PS ;

Cooper, JP ;

Collins, JL ;

Dezube, M ;

Henke, BR ;

Hull-Ryde, EA ;

Lake, DH ;

Lenhard, JM ;

Oliver, W ;

Oplinger, J ;

Pentti, M ;

Parks, DJ ;

Plunket, KD ;

Tong, WQ .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (25) :5055-5069

[4] Isoxazolyl, oxazolyl, and thiazolylpropionic acid derivatives as potent α4β1 integrin antagonists [J].

Duplantier, AJ ;

Beckius, GE ;

Chambers, RJ ;

Chupak, LS ;

Jenkinson, TH ;

Klein, AS ;

Kraus, KG ;

Kudlacz, EM ;

McKechney, MW ;

Pettersson, M ;

Whitney, CA ;

Milici, AJ .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (19) :2593-2596

[5]

ELICES M, 1999, CURR OPIN ANTIINFLAM, V1, P14

[6]

FRINK EJ, 1990, ANESTH ANALG, V71, P484

[7] The discovery of sulfonylated dipeptides as potent VLA-4 antagonists [J].

Hagmann, WK ;

Durette, PL ;

Lanza, T ;

Kevin, NJ ;

de Laszlo, SE ;

Kopka, HE ;

Young, D ;

Magriotis, PA ;

Li, B ;

Lin, LS ;

Yang, G ;

Kamenecka, T ;

Chang, LL ;

Wilson, J ;

MacCoss, M ;

Mills, SG ;

Van Riper, G ;

McCauley, E ;

Egger, LA ;

Kidambi, U ;

Lyons, K ;

Vincent, S ;

Stearns, R ;

Colletti, A ;

Teffera, J ;

Tong, S ;

Fenyk-Melody, J ;

Owens, K ;

Levorse, D ;

Kim, P ;

Schmidt, JA ;

Mumford, RA .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) :2709-2713

[8] Discovery and evaluation of piperidinyl carboxylic acid derivatives as potent α4β1 integrin antagonists [J].

Müller, G ;

Albers, M ;

Fischer, R ;

Hessler, G ;

Lehmann, TE ;

Okigami, H ;

Tajimi, M ;

Bacon, K ;

Rölle, T .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (23) :3019-3021

[9]

Porter J R, 2000, IDrugs, V3, P788

[10] Discovery and evaluation of N-(triazin-1,3,5-yl) phenylalanine derivatives as VLA-4 integrin antagonists [J].

Porter, JR ;

Archibald, SC ;

Brown, JA ;

Childs, K ;

Critchley, D ;

Head, JC ;

Hutchinson, B ;

Parton, TAH ;

Robinson, MK ;

Shock, A ;

Warrellow, GJ ;

Zomaya, A .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (12) :1591-1594

← 1 2 →